Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
November 2, 2020
Safety of Axicabtagene Ciloleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
Allison Grana, Natalia Gut, Kiersten Williams, et al.
Transplantation and Cellular Therapy
|
March 29, 2026
Phase I Trial of Venetoclax and BEAM followed by Autologous Stem Cell Transplant for High-Risk non-Hodgkin Lymphoma
Joseph E Maakaron, Qiuhong Zhao, Jayalakshmi P Balakrishna, et al.
Cytometry. Part B, Clinical Cytometry
|
February 12, 2024
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies
Philip G Woost, Basem M William, Brenda W Cooper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 21, 2017
Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis
Basem M William, Tao Wang, Michael D Haagenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 23, 2018
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
Marcos de Lima, Betul Oran, Richard E Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 5, 2015
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment
Manuel Afable, Paolo F Caimi, Chitra Hosing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 19, 2015
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients
Paolo F Caimi, Basem M William, Carlos H Silva Rondon, et al.
British Journal of Haematology
|
December 7, 2018
Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma
Jayadev M Umakanthan, Javeed Iqbal, Connie L Batlevi, et al.
The Lancet. Oncology
|
June 30, 2019
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
Martine Bagot, Pierluigi Porcu, Anne Marie-Cardine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2019
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study
Khoan Vu, Chi-Heng Wu, Chen-Yen Yang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Clinical Lymphoma, Myeloma & Leukemia
|
November 2, 2020
Safety of Axicabtagene Ciloleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma
Allison Grana, Natalia Gut, Kiersten Williams, et al.
Transplantation and Cellular Therapy
|
March 29, 2026
Phase I Trial of Venetoclax and BEAM followed by Autologous Stem Cell Transplant for High-Risk non-Hodgkin Lymphoma
Joseph E Maakaron, Qiuhong Zhao, Jayalakshmi P Balakrishna, et al.
Cytometry. Part B, Clinical Cytometry
|
February 12, 2024
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies
Philip G Woost, Basem M William, Brenda W Cooper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 21, 2017
Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis
Basem M William, Tao Wang, Michael D Haagenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 23, 2018
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
Marcos de Lima, Betul Oran, Richard E Champlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 5, 2015
Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment
Manuel Afable, Paolo F Caimi, Chitra Hosing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 19, 2015
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients
Paolo F Caimi, Basem M William, Carlos H Silva Rondon, et al.
British Journal of Haematology
|
December 7, 2018
Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma
Jayadev M Umakanthan, Javeed Iqbal, Connie L Batlevi, et al.
The Lancet. Oncology
|
June 30, 2019
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
Martine Bagot, Pierluigi Porcu, Anne Marie-Cardine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2019
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study
Khoan Vu, Chi-Heng Wu, Chen-Yen Yang, et al.
Page
of 6